Emer Cooke, Shutterstock

EMA in­ves­ti­gat­ing 4 'se­ri­ous cas­es' of blood clots fol­low­ing J&J vac­ci­na­tions

The Eu­ro­pean Med­i­cines Agency’s safe­ty com­mit­tee said last Fri­day that it has ini­ti­at­ed a re­view of 4 “se­ri­ous cas­es of un­usu­al blood clots with low blood platelets,” in­clud­ing one death, re­port­ed af­ter peo­ple re­ceived the J&J vac­cine in the US.

The agency of­fered an up­date on Wednes­day that it is ex­pe­dit­ing this eval­u­a­tion and cur­rent­ly ex­pects to is­sue a rec­om­men­da­tion next week. “While its re­view is on­go­ing, EMA re­mains of the view that the ben­e­fits of the vac­cine in pre­vent­ing COVID-19 out­weigh the risks of side ef­fects,” the agency said in a state­ment. J&J an­nounced on Tues­day that it would pause the dis­tri­b­u­tion of its vac­cine across Eu­rope un­til the in­ves­ti­ga­tions are com­plete.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters